Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
New words:
affirmative, annum, assigned, bankruptcy, bear, bound, carrying, Center, closing, collateral, compliance, consent, correct, covenant, cure, death, declared, default, delivery, discount, disease, efficient, encumber, encumbrance, expand, focused, foreseeable, GAAP, greater, higher, iii, insurance, issuance, Journal, lender, LIBOR, lien, loan, made, mentioned, minimum, monthly, negative, occurrence, orphan, Oxford, partnership, pay, permitted, personal, point, prepay, prepayment, rendering, repaid, repayment, representation, reserved, respond, retained, settled, Southwest, Street, thereunder, University, volume, Wall, warranty, written
Removed:
acceptance, account, accrual, achievement, Administration, apply, ASC, assessment, ATTENTION, baseline, began, beginning, Beryllium, Beta, blood, breast, candidate, carcinoma, CEO, cetuximab, claim, CMO, cohort, collaborated, combined, Commencing, commensurate, commercialized, committee, compare, compound, conclude, conducting, confirmed, continually, COO, country, covering, credited, CTEP, decision, digit, disorder, DMC, dose, dosing, double, earn, eligible, EMA, employed, endometrial, enriched, enrolled, enrolling, enrollment, entitling, erlotinib, EU, European, excluded, expansion, explore, extended, extension, factor, FDA, fibroblast, Food, formation, France, gastric, gene, generation, Genome, Germany, growth, guide, head, hepatocellular, implementing, independent, insolvency, Institute, investigating, involving, Italy, Japanese, jointly, kidney, launch, licensing, light, line, literature, liver, longer, lower, lymphoma, magnitude, malignant, manufacture, MARQUEE, maximum, mesothelioma, METIV, milestone, modify, monitoring, myeloma, NCI, neck, notably, noted, November, NSCLC, observation, observed, official, originally, outcome, overgrowth, pancreatic, partial, partially, patent, pending, percent, placebo, proliferation, prostate, Protocol, receipt, recommendation, resistance, responsible, reviewed, royalty, scientific, Similarly, sorafenib, SPA, Spain, spread, subsequently, terminated, termination, territory, tied, tiered, transaction, treatment, tumor, UK, United, valid, variety, vessel, working, worldwide
Filing tables
Filing exhibits
Related press release
ARQL similar filings
Filing view
External links